Antioxidants and Cardiovascular Disease

  • Martial G. Bourassa
  • Jean-Claude Tardif

Part of the Developments in Cardiovascular Medicine book series (DICM, volume 258)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Ulf Landmesser, Helmut Drexler
    Pages 1-15
  3. Sotirios Tsimikas
    Pages 17-48
  4. Juan Viles-Gonzalez, Juan J. Badimon, Valentin Fuster
    Pages 49-85
  5. Charlene Bierl, Marc Forgione, Joseph Loscalzo
    Pages 87-101
  6. Ian A. Blair, John A Lawson, Harry Ischiropoulos, Garret A. FitzGerald
    Pages 131-165
  7. Sergey Dikalov, David G. Harrison
    Pages 167-194
  8. Tillman Cyprus, Domenico Pratico
    Pages 227-253
  9. Martial G. Bourassa, Jean-Claude Tardif
    Pages 255-277
  10. Christian Bingelli, Isabella Sudano, Bernd van der Loo, Francesco Cosentino, Georg Noll, Thomas F. Lüscher
    Pages 279-304
  11. Eric Durand, Ayman Al Haj Zen, Camille Brasselet, Antoine Lafont
    Pages 327-336
  12. Martial G. Bourassa, Jean-Claude Tardif
    Pages 337-361
  13. Ernesto L. Schiffrin, Rhian M. Touyz
    Pages 363-379
  14. Jean-Louis Chiasson, Rémi Rabasa-Lhoret, Ashok K. Srivastava
    Pages 381-397
  15. Douglas B. Sawyer, Wilson S. Colucci
    Pages 437-450
  16. Anique Ducharme, Jean Lucien Rouleau, Michel White
    Pages 451-476

About this book

Introduction

Antioxidants and Cardiovascular Disease, Second Edition addresses a complex but very timely and fascinating problem in cardiovascular medicine. It is written by recognized experts in the fields of atherosclerosis and antioxidants. It should be of interest not only to academicians but also to practicing physicians. The first five chapters review the general concepts of oxidative stress and their relationship to lipid metabolism, endothelial dysfunction, genetics and transcriptional factors. The next seven chapters describe recently defined markers of oxidative stress, pharmacological compounds with antioxidant activity, natural antioxidants found in micronutrients and in nutrient-rich diets, and reviews the recent evidence for their efficacy or lack of efficacy in patients with cardiovascular disease or cardiovascular risk factors. The last seven chapters discuss the potential therapeutic benefits of antioxidants in a number of cardiovascular conditions which include atherosclerosis, restenosis after percutaneous coronary intervention, major cardiovascular risk factors such as hypertension, diabetes mellitus and dyslipidemia, and left ventricular dysfunction and congestive heart failure.

Martial G. Bourassa, M.D. and Jean-Claude Tardif, M.D. are affiliated with the Montreal Heart Institute, Research Center and Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.

Keywords

Lipoprotein atherosclerosis cardiovascular coronary artery disease heart hypertension vascular disease

Editors and affiliations

  • Martial G. Bourassa
    • 1
  • Jean-Claude Tardif
    • 1
  1. 1.Montreal Heart Institute Research Center and Department of Medicine, Faculty of MedicineUniversity of MontrealMontrealCanada

Bibliographic information

  • DOI https://doi.org/10.1007/0-387-29553-4
  • Copyright Information Springer Science+Business Media, Inc. 2006
  • Publisher Name Springer, Boston, MA
  • eBook Packages Medicine
  • Print ISBN 978-0-387-29552-7
  • Online ISBN 978-0-387-29553-4
  • Series Print ISSN 0166-9842
  • About this book